Retrospective Study
Copyright ©The Author(s) 2018.
World J Diabetes. Feb 15, 2018; 9(2): 53-58
Published online Feb 15, 2018. doi: 10.4239/wjd.v9.i2.53
Table 1 Changes in paired A1C and random blood glucose surrounding medication-initiation events
MedicationnDifference (mg/dL or % glycosylation)Confidence intervalP value
Random blood glucose
Etanercept311-0.06-4.914.790.98
Adalimumab3021.03-3.415.460.65
Certolizumab5-5.20-26.6016.190.54
Golimumab13-17.61-37.542.310.08
Infliximab147-1.90-9.455.650.62
Methotrexate8312.08-7.484.900.15
Leflunomide290-0.48-6.845.880.88
Hydroxychloroquine653-3.68-7.150.200.04
Sulfasalazine335-0.38-4.924.170.87
Prednisone6655.852.209.51< 0.01
Hemoglobin A1C
Etanercept35-0.17-0.500.170.33
Adalimumab430.04-0.340.420.83
Certolizumab10.20n/an/an/a
Golimumab4-0.65-3.472.170.52
Infliximab20-0.36-0.950.230.22
Methotrexate107-0.11-0.350.140.40
Leflunomide51-0.02-0.400.350.91
Hydroxychloroquine98-0.15-0.400.110.25
Sulfasalazine49-0.70-1.080.31< 0.01
Prednisone68-0.01-0.250.240.96